Table 1.
Pre-treatment characteristics of the 2 groups
| Parameters | HA-CS, n = 30 (56.6%) | HA, n = 23 (43.3%) | p value |
|---|---|---|---|
| Age, years | 48.47 ± 14.73 | 49.61 ± 16.59 | 0.792 |
| VAS | 8.2 ± 2.09 | 8 ± 2.88 | 0.703 |
| Micturition frequency (24-hour): mean ± SD | 15.1 ± 7.03 | 14.8 ± 6.47 | 0.978 |
| Nocturia, mean ± SD | 3.1 ± 2.40 | 3.1 ± 2.55 | 0.971 |
| ICSI | 15.2 ± 3.57 | 15.2 ± 3.95 | 0.870 |
| ICPI | 13.2 ± 2.52 | 13.3 ± 2.70 | 0.827 |
| Cystometric capacity (mL), mean ± SD | 301.6 ± 121.92 | 286.2 ± 127.24 | 0.654 |
| Voided volume (mL), mean ± SD | 154.6 ± 94.17 | 151 ± 90.59 | 0.914 |
| PST positivity rate (%) | 76.7% | 65.2% | 0.082 |
HA: hyaluronic acid; CS: chondroitin sulphate; VAS: visual analog pain scale; ICSI: interstitial cystitis symptom index; ICPI: interstitial cystitis problem index; PST: potassium sensitivity test; SD: standard deviation; SD: standard deviation.